Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d7b5c6fdd4dac190eb625b9d1332a1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C219-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D339-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C327-48 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C331-28 |
filingDate |
2007-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0138bf5affd9d2a5e4b1e9287bc38ee8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02666b6ab861b901839cbcfc9033f5f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b61477d9eb79a1cbca4806270adc6e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8a6e6899a5034b0570ecf4b25eeb10e |
publicationDate |
2010-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7741359-B2 |
titleOfInvention |
Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
abstract |
The present invention relates to derivatives of non-steroidal anti-inflammatory drugs (NSAIDs) having improved anti-inflammatory properties useful in the treatment of inflammation, pain and fever. More particularly, NSAIDs are derivatized with a hydrogen sulfide (H 2 S) releasing moiety to produce novel anti-inflammatory compounds having reduced side effects. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8541398-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9630909-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8771755-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010210607-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013055199-A1 |
priorityDate |
2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |